These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12463730)

  • 41. Effect of omega-3-acid ethyl esters on the steady-state plasma pharmacokinetics of rosuvastatin in healthy adults.
    Gosai P; Liu J; Doyle RT; Johnson J; Carter R; Sica D; McKenney JM
    Expert Opin Pharmacother; 2008 Dec; 9(17):2947-53. PubMed ID: 19006471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects.
    Jung JA; Lee SY; Kim JR; Ko JW; Jang SB; Nam SY; Huh W
    Drug Des Devel Ther; 2015; 9():745-52. PubMed ID: 25767372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians.
    Lee J; Rhee SJ; Lee S; Yu KS
    Drug Des Devel Ther; 2018; 12():787-794. PubMed ID: 29670335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single-dose, 2-way crossover, bioequivalence study of two rosuvastatin formulations in normal healthy subjects under fasting conditions.
    Trabelsi F; Bartůnek A; Vlavonou R; Navrátilová L; Dubé C; Tanguay M; Hauser T
    Int J Clin Pharmacol Ther; 2012 Oct; 50(10):741-50. PubMed ID: 22762855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic effects of fluvastatin in patients chronically receiving digoxin.
    Garnett WR; Venitz J; Wilkens RC; Dimenna G
    Am J Med; 1994 Jun; 96(6A):84S-86S. PubMed ID: 8017472
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aleglitazar, a balanced PPARα/γ agonist, has no clinically relevant pharmacokinetic interaction with high-dose atorvastatin or rosuvastatin.
    Foley-Comer AJ; Young AM; Russell-Yarde F; Jordan P
    Expert Opin Investig Drugs; 2011 Jan; 20(1):3-12. PubMed ID: 21114416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Absence of an effect of a single-dose deferasirox on the steady-state pharmacokinetics of digoxin.
    Sechaud R; Robeva A; Belleli R; Balez S
    Int J Clin Pharmacol Ther; 2008 Oct; 46(10):519-26. PubMed ID: 18826866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of lacosamide on the steady-state pharmacokinetics of digoxin: results from a phase I, multiple-dose, double-blind, randomised, placebo-controlled, crossover trial.
    Cawello W; Mueller-Voessing C; Andreas JO
    Clin Drug Investig; 2014 May; 34(5):327-34. PubMed ID: 24634110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. No effects of pantoprazole on the pharmacokinetics of rosuvastatin in healthy subjects.
    Huguet J; Lu J; Gaudette F; Chiasson JL; Hamet P; Michaud V; Turgeon J
    Eur J Clin Pharmacol; 2016 Aug; 72(8):925-31. PubMed ID: 27146814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacodynamic interaction between ezetimibe and rosuvastatin.
    Kosoglou T; Statkevich P; Yang B; Suresh R; Zhu Y; Boutros T; Maxwell SE; Tiessen R; Cutler DL
    Curr Med Res Opin; 2004 Aug; 20(8):1185-95. PubMed ID: 15324521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ABT-335, the choline salt of fenofibric acid, does not have a clinically significant pharmacokinetic interaction with rosuvastatin in humans.
    Zhu T; Awni WM; Hosmane B; Kelly MT; Sleep DJ; Stolzenbach JC; Wan K; Chira TO; Pradhan RS
    J Clin Pharmacol; 2009 Jan; 49(1):63-71. PubMed ID: 18952910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Longitudinal assessment of estimated glomerular filtration rate in apparently healthy adults: a post hoc analysis from the JUPITER study (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
    Vidt DG; Ridker PM; Monyak JT; Schreiber MJ; Cressman MD
    Clin Ther; 2011 Jun; 33(6):717-25. PubMed ID: 21704236
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Darexaban (YM150), an oral direct factor Xa inhibitor, has no effect on the pharmacokinetics of digoxin.
    Kadokura T; Groenendaal D; Heeringa M; Mol R; Verheggen F; Garcia-Hernandez A; Onkels H
    Eur J Drug Metab Pharmacokinet; 2014 Mar; 39(1):1-9. PubMed ID: 23754514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of Macitentan on the Pharmacokinetics of the Breast Cancer Resistance Protein Substrates, Rosuvastatin and Riociguat, in Healthy Male Subjects.
    Csonka D; Bruderer S; Schultz A; Soergel M; Stepanova R; Sabattini G; Perez-Ruixo JJ
    Clin Drug Investig; 2019 Dec; 39(12):1223-1232. PubMed ID: 31552642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of rosuvastatin on cytokines after traumatic head injury.
    Sánchez-Aguilar M; Tapia-Pérez JH; Sánchez-Rodríguez JJ; Viñas-Ríos JM; Martínez-Pérez P; de la Cruz-Mendoza E; Sánchez-Reyna M; Torres-Corzo JG; Gordillo-Moscoso A
    J Neurosurg; 2013 Mar; 118(3):669-75. PubMed ID: 23289819
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics and disposition of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rat.
    Nezasa K; Takao A; Kimura K; Takaichi M; Inazawa K; Koike M
    Xenobiotica; 2002 Aug; 32(8):715-27. PubMed ID: 12296991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of Omeprazole on the Pharmacokinetics of Rosuvastatin in Healthy Male Volunteers.
    Shah Y; Iqbal Z; Ahmad L; Khuda F; Khan A; Khan A; Khan MI; Ismail
    Am J Ther; 2016; 23(6):e1514-e1523. PubMed ID: 25719441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of a single gemfibrozil dose on the pharmacokinetics of rosuvastatin in bile and plasma in healthy volunteers.
    Bergman E; Matsson EM; Hedeland M; Bondesson U; Knutson L; Lennernäs H
    J Clin Pharmacol; 2010 Sep; 50(9):1039-49. PubMed ID: 20150523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetic interaction of sparfloxacin and digoxin.
    Johnson RD; Dorr MB; Hunt TL; Conway S; Talbot GH
    Clin Ther; 1999 Feb; 21(2):368-79. PubMed ID: 10211539
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of herbal medicine baicalin on pharmacokinetics of rosuvastatin, substrate of organic anion-transporting polypeptide 1B1.
    Fan L; Zhang W; Guo D; Tan ZR; Xu P; Li Q; Liu YZ; Zhang L; He TY; Hu DL; Wang D; Zhou HH
    Clin Pharmacol Ther; 2008 Mar; 83(3):471-6. PubMed ID: 17851565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.